nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—CYP3A7—Vincristine—muscle cancer	0.173	0.239	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.173	0.239	CbGbCtD
Fluticasone Propionate—CYP3A5—Vincristine—muscle cancer	0.129	0.179	CbGbCtD
Fluticasone Propionate—CYP3A5—Etoposide—muscle cancer	0.119	0.164	CbGbCtD
Fluticasone Propionate—CYP3A4—Vincristine—muscle cancer	0.0505	0.07	CbGbCtD
Fluticasone Propionate—CYP3A4—Etoposide—muscle cancer	0.0463	0.0641	CbGbCtD
Fluticasone Propionate—CYP3A4—Doxorubicin—muscle cancer	0.0316	0.0437	CbGbCtD
Fluticasone Propionate—PLA2G4A—Raltitrexed—Methotrexate—muscle cancer	0.0163	1	CbGdCrCtD
Fluticasone Propionate—Growth retardation—Dactinomycin—muscle cancer	0.0132	0.0629	CcSEcCtD
Fluticasone Propionate—Telangiectasia—Methotrexate—muscle cancer	0.0055	0.0263	CcSEcCtD
Fluticasone Propionate—Bronchial hyperreactivity—Methotrexate—muscle cancer	0.00497	0.0237	CcSEcCtD
Fluticasone Propionate—Folliculitis—Dactinomycin—muscle cancer	0.00476	0.0227	CcSEcCtD
Fluticasone Propionate—Chronic obstructive pulmonary disease—Methotrexate—muscle cancer	0.00454	0.0216	CcSEcCtD
Fluticasone Propionate—Secondary infection—Doxorubicin—muscle cancer	0.00382	0.0182	CcSEcCtD
Fluticasone Propionate—Leukoderma—Methotrexate—muscle cancer	0.00305	0.0146	CcSEcCtD
Fluticasone Propionate—PLA2G4A—smooth muscle tissue—muscle cancer	0.00289	0.055	CbGeAlD
Fluticasone Propionate—PLA2G4A—renal system—muscle cancer	0.00279	0.053	CbGeAlD
Fluticasone Propionate—SERPINA6—renal system—muscle cancer	0.00277	0.0528	CbGeAlD
Fluticasone Propionate—Leukoderma—Doxorubicin—muscle cancer	0.00264	0.0126	CcSEcCtD
Fluticasone Propionate—NR3C2—smooth muscle tissue—muscle cancer	0.00235	0.0448	CbGeAlD
Fluticasone Propionate—Osteoporosis—Methotrexate—muscle cancer	0.00231	0.011	CcSEcCtD
Fluticasone Propionate—NR3C2—renal system—muscle cancer	0.00226	0.0431	CbGeAlD
Fluticasone Propionate—Multiple fractures—Methotrexate—muscle cancer	0.00223	0.0106	CcSEcCtD
Fluticasone Propionate—Fracture—Methotrexate—muscle cancer	0.00223	0.0106	CcSEcCtD
Fluticasone Propionate—PGR—smooth muscle tissue—muscle cancer	0.00219	0.0416	CbGeAlD
Fluticasone Propionate—PLA2G4A—tendon—muscle cancer	0.00217	0.0414	CbGeAlD
Fluticasone Propionate—PLA2G4A—bone marrow—muscle cancer	0.00211	0.0401	CbGeAlD
Fluticasone Propionate—SERPINA6—bone marrow—muscle cancer	0.0021	0.0399	CbGeAlD
Fluticasone Propionate—Candida infection—Etoposide—muscle cancer	0.00207	0.00986	CcSEcCtD
Fluticasone Propionate—Psoriasis—Methotrexate—muscle cancer	0.00206	0.00984	CcSEcCtD
Fluticasone Propionate—Folliculitis—Methotrexate—muscle cancer	0.00206	0.00984	CcSEcCtD
Fluticasone Propionate—NR3C2—cardiac atrium—muscle cancer	0.00203	0.0386	CbGeAlD
Fluticasone Propionate—PLA2G4A—vagina—muscle cancer	0.00202	0.0384	CbGeAlD
Fluticasone Propionate—Lacrimation—Doxorubicin—muscle cancer	0.00191	0.00911	CcSEcCtD
Fluticasone Propionate—SERPINA6—head—muscle cancer	0.00186	0.0353	CbGeAlD
Fluticasone Propionate—PLA2G4A—testis—muscle cancer	0.0018	0.0342	CbGeAlD
Fluticasone Propionate—Psoriasis—Doxorubicin—muscle cancer	0.00179	0.00852	CcSEcCtD
Fluticasone Propionate—Folliculitis—Doxorubicin—muscle cancer	0.00179	0.00852	CcSEcCtD
Fluticasone Propionate—NR3C2—tendon—muscle cancer	0.00177	0.0336	CbGeAlD
Fluticasone Propionate—Oral candidiasis—Doxorubicin—muscle cancer	0.00177	0.00843	CcSEcCtD
Fluticasone Propionate—Pneumonia—Dactinomycin—muscle cancer	0.00168	0.00803	CcSEcCtD
Fluticasone Propionate—NR3C2—vagina—muscle cancer	0.00164	0.0312	CbGeAlD
Fluticasone Propionate—Anaphylactoid reaction—Etoposide—muscle cancer	0.00162	0.00775	CcSEcCtD
Fluticasone Propionate—NR3C1—embryo—muscle cancer	0.00161	0.0305	CbGeAlD
Fluticasone Propionate—Blister—Doxorubicin—muscle cancer	0.00156	0.00743	CcSEcCtD
Fluticasone Propionate—PGR—vagina—muscle cancer	0.00153	0.029	CbGeAlD
Fluticasone Propionate—Dermatitis atopic—Doxorubicin—muscle cancer	0.00152	0.00724	CcSEcCtD
Fluticasone Propionate—NR3C2—head—muscle cancer	0.00152	0.0288	CbGeAlD
Fluticasone Propionate—Pneumonia—Vincristine—muscle cancer	0.0015	0.00717	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Dactinomycin—muscle cancer	0.00149	0.00711	CcSEcCtD
Fluticasone Propionate—Rash erythematous—Doxorubicin—muscle cancer	0.00147	0.00699	CcSEcCtD
Fluticasone Propionate—NR3C2—testis—muscle cancer	0.00146	0.0278	CbGeAlD
Fluticasone Propionate—Cramp muscle—Etoposide—muscle cancer	0.00141	0.00675	CcSEcCtD
Fluticasone Propionate—PGR—head—muscle cancer	0.00141	0.0268	CbGeAlD
Fluticasone Propionate—Herpes simplex—Methotrexate—muscle cancer	0.00141	0.00671	CcSEcCtD
Fluticasone Propionate—Ageusia—Doxorubicin—muscle cancer	0.00139	0.00661	CcSEcCtD
Fluticasone Propionate—Stinging—Doxorubicin—muscle cancer	0.00139	0.00661	CcSEcCtD
Fluticasone Propionate—Dysphonia—Doxorubicin—muscle cancer	0.00136	0.00651	CcSEcCtD
Fluticasone Propionate—PGR—testis—muscle cancer	0.00136	0.0259	CbGeAlD
Fluticasone Propionate—Bronchospasm—Etoposide—muscle cancer	0.00134	0.00637	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Vincristine—muscle cancer	0.00133	0.00637	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Vincristine—muscle cancer	0.00132	0.00629	CcSEcCtD
Fluticasone Propionate—Erythema—Dactinomycin—muscle cancer	0.00131	0.00624	CcSEcCtD
Fluticasone Propionate—NR3C1—smooth muscle tissue—muscle cancer	0.00126	0.024	CbGeAlD
Fluticasone Propionate—Cardiac disorder—Vincristine—muscle cancer	0.00124	0.00594	CcSEcCtD
Fluticasone Propionate—Viral infection—Doxorubicin—muscle cancer	0.00124	0.00593	CcSEcCtD
Fluticasone Propionate—CYP3A5—renal system—muscle cancer	0.00122	0.0233	CbGeAlD
Fluticasone Propionate—Lacrimation increased—Doxorubicin—muscle cancer	0.00122	0.00581	CcSEcCtD
Fluticasone Propionate—Herpes simplex—Doxorubicin—muscle cancer	0.00122	0.00581	CcSEcCtD
Fluticasone Propionate—Pneumonia—Etoposide—muscle cancer	0.00122	0.00581	CcSEcCtD
Fluticasone Propionate—NR3C1—renal system—muscle cancer	0.00121	0.0231	CbGeAlD
Fluticasone Propionate—Ill-defined disorder—Dactinomycin—muscle cancer	0.00121	0.00579	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Etoposide—muscle cancer	0.00121	0.00578	CcSEcCtD
Fluticasone Propionate—Infestation—Etoposide—muscle cancer	0.00121	0.00578	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Vincristine—muscle cancer	0.00121	0.00577	CcSEcCtD
Fluticasone Propionate—Malaise—Dactinomycin—muscle cancer	0.00118	0.00563	CcSEcCtD
Fluticasone Propionate—Mental disorder—Vincristine—muscle cancer	0.00118	0.00561	CcSEcCtD
Fluticasone Propionate—Dermatitis contact—Doxorubicin—muscle cancer	0.00111	0.00529	CcSEcCtD
Fluticasone Propionate—Discomfort—Dactinomycin—muscle cancer	0.0011	0.00525	CcSEcCtD
Fluticasone Propionate—Influenza like illness—Doxorubicin—muscle cancer	0.00109	0.0052	CcSEcCtD
Fluticasone Propionate—NR3C1—cardiac atrium—muscle cancer	0.00109	0.0207	CbGeAlD
Fluticasone Propionate—Diabetes mellitus—Methotrexate—muscle cancer	0.00108	0.00516	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Etoposide—muscle cancer	0.00108	0.00516	CcSEcCtD
Fluticasone Propionate—Agitation—Vincristine—muscle cancer	0.00107	0.00512	CcSEcCtD
Fluticasone Propionate—Candida infection—Doxorubicin—muscle cancer	0.00107	0.00511	CcSEcCtD
Fluticasone Propionate—Oedema—Dactinomycin—muscle cancer	0.00107	0.00509	CcSEcCtD
Fluticasone Propionate—Infection—Dactinomycin—muscle cancer	0.00106	0.00506	CcSEcCtD
Fluticasone Propionate—Eye disorder—Etoposide—muscle cancer	0.00102	0.00485	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Etoposide—muscle cancer	0.00101	0.00481	CcSEcCtD
Fluticasone Propionate—Hypertension—Vincristine—muscle cancer	0.00101	0.00481	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Etoposide—muscle cancer	0.000981	0.00468	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Etoposide—muscle cancer	0.000979	0.00467	CcSEcCtD
Fluticasone Propionate—Anaphylactoid reaction—Methotrexate—muscle cancer	0.000972	0.00464	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000972	0.00464	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Vincristine—muscle cancer	0.000953	0.00455	CcSEcCtD
Fluticasone Propionate—Oedema—Vincristine—muscle cancer	0.000953	0.00455	CcSEcCtD
Fluticasone Propionate—NR3C1—tendon—muscle cancer	0.000948	0.018	CbGeAlD
Fluticasone Propionate—Infection—Vincristine—muscle cancer	0.000947	0.00452	CcSEcCtD
Fluticasone Propionate—Diabetes mellitus—Doxorubicin—muscle cancer	0.000937	0.00447	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Vincristine—muscle cancer	0.000935	0.00446	CcSEcCtD
Fluticasone Propionate—CYP3A4—renal system—muscle cancer	0.000919	0.0175	CbGeAlD
Fluticasone Propionate—NR3C1—bone marrow—muscle cancer	0.000919	0.0175	CbGeAlD
Fluticasone Propionate—Pain—Dactinomycin—muscle cancer	0.000912	0.00435	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Etoposide—muscle cancer	0.000909	0.00434	CcSEcCtD
Fluticasone Propionate—Eczema—Doxorubicin—muscle cancer	0.000906	0.00433	CcSEcCtD
Fluticasone Propionate—Irritability—Methotrexate—muscle cancer	0.000898	0.00429	CcSEcCtD
Fluticasone Propionate—CYP3A5—vagina—muscle cancer	0.000887	0.0169	CbGeAlD
Fluticasone Propionate—NR3C1—vagina—muscle cancer	0.00088	0.0167	CbGeAlD
Fluticasone Propionate—Feeling abnormal—Dactinomycin—muscle cancer	0.000879	0.0042	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Etoposide—muscle cancer	0.000878	0.00419	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000872	0.00416	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000868	0.00414	CcSEcCtD
Fluticasone Propionate—Malaise—Etoposide—muscle cancer	0.000853	0.00407	CcSEcCtD
Fluticasone Propionate—Dermatitis bullous—Doxorubicin—muscle cancer	0.000852	0.00407	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Dactinomycin—muscle cancer	0.000843	0.00402	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Dactinomycin—muscle cancer	0.000843	0.00402	CcSEcCtD
Fluticasone Propionate—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000842	0.00402	CcSEcCtD
Fluticasone Propionate—Cough—Etoposide—muscle cancer	0.000825	0.00394	CcSEcCtD
Fluticasone Propionate—Hypertension—Etoposide—muscle cancer	0.000817	0.0039	CcSEcCtD
Fluticasone Propionate—Pain—Vincristine—muscle cancer	0.000815	0.00389	CcSEcCtD
Fluticasone Propionate—Asthma—Methotrexate—muscle cancer	0.000813	0.00388	CcSEcCtD
Fluticasone Propionate—NR3C1—head—muscle cancer	0.000813	0.0155	CbGeAlD
Fluticasone Propionate—Chest pain—Etoposide—muscle cancer	0.000805	0.00384	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.0008	0.00382	CcSEcCtD
Fluticasone Propionate—Discomfort—Etoposide—muscle cancer	0.000796	0.0038	CcSEcCtD
Fluticasone Propionate—Face oedema—Doxorubicin—muscle cancer	0.000786	0.00375	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Dactinomycin—muscle cancer	0.000786	0.00375	CcSEcCtD
Fluticasone Propionate—NR3C1—testis—muscle cancer	0.000785	0.0149	CbGeAlD
Fluticasone Propionate—Abdominal discomfort—Methotrexate—muscle cancer	0.000779	0.00372	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Vincristine—muscle cancer	0.000779	0.00372	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Etoposide—muscle cancer	0.000772	0.00368	CcSEcCtD
Fluticasone Propionate—Infection—Etoposide—muscle cancer	0.000767	0.00366	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000756	0.00361	CcSEcCtD
Fluticasone Propionate—Tachycardia—Etoposide—muscle cancer	0.000753	0.0036	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Vincristine—muscle cancer	0.000753	0.0036	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Vincristine—muscle cancer	0.000753	0.0036	CcSEcCtD
Fluticasone Propionate—Skin disorder—Etoposide—muscle cancer	0.00075	0.00358	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Dactinomycin—muscle cancer	0.00073	0.00348	CcSEcCtD
Fluticasone Propionate—Pneumonia—Methotrexate—muscle cancer	0.000729	0.00348	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Doxorubicin—muscle cancer	0.000728	0.00348	CcSEcCtD
Fluticasone Propionate—Infestation—Methotrexate—muscle cancer	0.000725	0.00346	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Methotrexate—muscle cancer	0.000725	0.00346	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Doxorubicin—muscle cancer	0.000709	0.00338	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Methotrexate—muscle cancer	0.000705	0.00336	CcSEcCtD
Fluticasone Propionate—Asthma—Doxorubicin—muscle cancer	0.000704	0.00336	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Vincristine—muscle cancer	0.000702	0.00335	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Etoposide—muscle cancer	0.000688	0.00328	CcSEcCtD
Fluticasone Propionate—Epistaxis—Methotrexate—muscle cancer	0.000684	0.00326	CcSEcCtD
Fluticasone Propionate—Vomiting—Dactinomycin—muscle cancer	0.000678	0.00324	CcSEcCtD
Fluticasone Propionate—Bronchitis—Doxorubicin—muscle cancer	0.000677	0.00323	CcSEcCtD
Fluticasone Propionate—Rash—Dactinomycin—muscle cancer	0.000672	0.00321	CcSEcCtD
Fluticasone Propionate—Pain—Etoposide—muscle cancer	0.00066	0.00315	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000654	0.00312	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Vincristine—muscle cancer	0.000652	0.00311	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Methotrexate—muscle cancer	0.000646	0.00308	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Etoposide—muscle cancer	0.000636	0.00304	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Doxorubicin—muscle cancer	0.000635	0.00303	CcSEcCtD
Fluticasone Propionate—Nausea—Dactinomycin—muscle cancer	0.000634	0.00302	CcSEcCtD
Fluticasone Propionate—Pneumonia—Doxorubicin—muscle cancer	0.000631	0.00301	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Etoposide—muscle cancer	0.000631	0.00301	CcSEcCtD
Fluticasone Propionate—Dizziness—Vincristine—muscle cancer	0.00063	0.00301	CcSEcCtD
Fluticasone Propionate—Infestation—Doxorubicin—muscle cancer	0.000628	0.003	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Doxorubicin—muscle cancer	0.000628	0.003	CcSEcCtD
Fluticasone Propionate—Urticaria—Etoposide—muscle cancer	0.000613	0.00293	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Etoposide—muscle cancer	0.00061	0.00291	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Etoposide—muscle cancer	0.00061	0.00291	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Doxorubicin—muscle cancer	0.00061	0.00291	CcSEcCtD
Fluticasone Propionate—Eye disorder—Methotrexate—muscle cancer	0.000608	0.0029	CcSEcCtD
Fluticasone Propionate—Vomiting—Vincristine—muscle cancer	0.000606	0.00289	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Methotrexate—muscle cancer	0.000604	0.00288	CcSEcCtD
Fluticasone Propionate—Rash—Vincristine—muscle cancer	0.000601	0.00287	CcSEcCtD
Fluticasone Propionate—Dermatitis—Vincristine—muscle cancer	0.0006	0.00287	CcSEcCtD
Fluticasone Propionate—Headache—Vincristine—muscle cancer	0.000597	0.00285	CcSEcCtD
Fluticasone Propionate—Epistaxis—Doxorubicin—muscle cancer	0.000592	0.00283	CcSEcCtD
Fluticasone Propionate—Sinusitis—Doxorubicin—muscle cancer	0.000589	0.00281	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Methotrexate—muscle cancer	0.000588	0.00281	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Methotrexate—muscle cancer	0.000587	0.0028	CcSEcCtD
Fluticasone Propionate—Mental disorder—Methotrexate—muscle cancer	0.00057	0.00272	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Etoposide—muscle cancer	0.000569	0.00271	CcSEcCtD
Fluticasone Propionate—Malnutrition—Methotrexate—muscle cancer	0.000567	0.0027	CcSEcCtD
Fluticasone Propionate—Erythema—Methotrexate—muscle cancer	0.000567	0.0027	CcSEcCtD
Fluticasone Propionate—Nausea—Vincristine—muscle cancer	0.000566	0.0027	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Doxorubicin—muscle cancer	0.000561	0.00268	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Doxorubicin—muscle cancer	0.000559	0.00267	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Doxorubicin—muscle cancer	0.000554	0.00264	CcSEcCtD
Fluticasone Propionate—Pruritus—Etoposide—muscle cancer	0.000546	0.00261	CcSEcCtD
Fluticasone Propionate—Vision blurred—Methotrexate—muscle cancer	0.000534	0.00255	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Etoposide—muscle cancer	0.000528	0.00252	CcSEcCtD
Fluticasone Propionate—Eye disorder—Doxorubicin—muscle cancer	0.000527	0.00251	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Methotrexate—muscle cancer	0.000526	0.00251	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Doxorubicin—muscle cancer	0.000523	0.0025	CcSEcCtD
Fluticasone Propionate—Malaise—Methotrexate—muscle cancer	0.000511	0.00244	CcSEcCtD
Fluticasone Propionate—Dizziness—Etoposide—muscle cancer	0.00051	0.00244	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Doxorubicin—muscle cancer	0.000509	0.00243	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Doxorubicin—muscle cancer	0.000508	0.00242	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Doxorubicin—muscle cancer	0.000503	0.0024	CcSEcCtD
Fluticasone Propionate—Cough—Methotrexate—muscle cancer	0.000494	0.00236	CcSEcCtD
Fluticasone Propionate—Mental disorder—Doxorubicin—muscle cancer	0.000494	0.00236	CcSEcCtD
Fluticasone Propionate—Vomiting—Etoposide—muscle cancer	0.000491	0.00234	CcSEcCtD
Fluticasone Propionate—Erythema—Doxorubicin—muscle cancer	0.000491	0.00234	CcSEcCtD
Fluticasone Propionate—Malnutrition—Doxorubicin—muscle cancer	0.000491	0.00234	CcSEcCtD
Fluticasone Propionate—Rash—Etoposide—muscle cancer	0.000487	0.00232	CcSEcCtD
Fluticasone Propionate—Dermatitis—Etoposide—muscle cancer	0.000486	0.00232	CcSEcCtD
Fluticasone Propionate—Headache—Etoposide—muscle cancer	0.000484	0.00231	CcSEcCtD
Fluticasone Propionate—Chest pain—Methotrexate—muscle cancer	0.000482	0.0023	CcSEcCtD
Fluticasone Propionate—Arthralgia—Methotrexate—muscle cancer	0.000482	0.0023	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000479	0.00229	CcSEcCtD
Fluticasone Propionate—Discomfort—Methotrexate—muscle cancer	0.000477	0.00227	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Doxorubicin—muscle cancer	0.000472	0.00225	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Methotrexate—muscle cancer	0.000462	0.00221	CcSEcCtD
Fluticasone Propionate—Vision blurred—Doxorubicin—muscle cancer	0.000462	0.00221	CcSEcCtD
Fluticasone Propionate—Infection—Methotrexate—muscle cancer	0.000459	0.00219	CcSEcCtD
Fluticasone Propionate—Nausea—Etoposide—muscle cancer	0.000459	0.00219	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Doxorubicin—muscle cancer	0.000455	0.00217	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Methotrexate—muscle cancer	0.000453	0.00216	CcSEcCtD
Fluticasone Propionate—Agitation—Doxorubicin—muscle cancer	0.000451	0.00215	CcSEcCtD
Fluticasone Propionate—Skin disorder—Methotrexate—muscle cancer	0.000449	0.00214	CcSEcCtD
Fluticasone Propionate—Malaise—Doxorubicin—muscle cancer	0.000442	0.00211	CcSEcCtD
Fluticasone Propionate—Palpitations—Doxorubicin—muscle cancer	0.000434	0.00207	CcSEcCtD
Fluticasone Propionate—Cough—Doxorubicin—muscle cancer	0.000428	0.00204	CcSEcCtD
Fluticasone Propionate—Hypertension—Doxorubicin—muscle cancer	0.000424	0.00202	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000421	0.00201	CcSEcCtD
Fluticasone Propionate—Arthralgia—Doxorubicin—muscle cancer	0.000418	0.00199	CcSEcCtD
Fluticasone Propionate—Chest pain—Doxorubicin—muscle cancer	0.000418	0.00199	CcSEcCtD
Fluticasone Propionate—Anxiety—Doxorubicin—muscle cancer	0.000416	0.00199	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000415	0.00198	CcSEcCtD
Fluticasone Propionate—Discomfort—Doxorubicin—muscle cancer	0.000413	0.00197	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Methotrexate—muscle cancer	0.000412	0.00197	CcSEcCtD
Fluticasone Propionate—Dry mouth—Doxorubicin—muscle cancer	0.000408	0.00195	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Doxorubicin—muscle cancer	0.0004	0.00191	CcSEcCtD
Fluticasone Propionate—Oedema—Doxorubicin—muscle cancer	0.0004	0.00191	CcSEcCtD
Fluticasone Propionate—Infection—Doxorubicin—muscle cancer	0.000398	0.0019	CcSEcCtD
Fluticasone Propionate—Pain—Methotrexate—muscle cancer	0.000395	0.00189	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Doxorubicin—muscle cancer	0.000393	0.00187	CcSEcCtD
Fluticasone Propionate—Tachycardia—Doxorubicin—muscle cancer	0.000391	0.00187	CcSEcCtD
Fluticasone Propionate—Skin disorder—Doxorubicin—muscle cancer	0.000389	0.00186	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Methotrexate—muscle cancer	0.000381	0.00182	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Methotrexate—muscle cancer	0.000378	0.0018	CcSEcCtD
Fluticasone Propionate—Urticaria—Methotrexate—muscle cancer	0.000367	0.00175	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Methotrexate—muscle cancer	0.000366	0.00174	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Methotrexate—muscle cancer	0.000366	0.00174	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000365	0.00174	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Doxorubicin—muscle cancer	0.000357	0.0017	CcSEcCtD
Fluticasone Propionate—Pain—Doxorubicin—muscle cancer	0.000342	0.00163	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Methotrexate—muscle cancer	0.000341	0.00163	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Doxorubicin—muscle cancer	0.00033	0.00157	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000327	0.00156	CcSEcCtD
Fluticasone Propionate—Pruritus—Methotrexate—muscle cancer	0.000327	0.00156	CcSEcCtD
Fluticasone Propionate—Urticaria—Doxorubicin—muscle cancer	0.000318	0.00152	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Doxorubicin—muscle cancer	0.000317	0.00151	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Doxorubicin—muscle cancer	0.000317	0.00151	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Methotrexate—muscle cancer	0.000316	0.00151	CcSEcCtD
Fluticasone Propionate—Dizziness—Methotrexate—muscle cancer	0.000306	0.00146	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Doxorubicin—muscle cancer	0.000295	0.00141	CcSEcCtD
Fluticasone Propionate—Vomiting—Methotrexate—muscle cancer	0.000294	0.0014	CcSEcCtD
Fluticasone Propionate—Rash—Methotrexate—muscle cancer	0.000292	0.00139	CcSEcCtD
Fluticasone Propionate—Dermatitis—Methotrexate—muscle cancer	0.000291	0.00139	CcSEcCtD
Fluticasone Propionate—Headache—Methotrexate—muscle cancer	0.00029	0.00138	CcSEcCtD
Fluticasone Propionate—Pruritus—Doxorubicin—muscle cancer	0.000283	0.00135	CcSEcCtD
Fluticasone Propionate—Nausea—Methotrexate—muscle cancer	0.000275	0.00131	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Doxorubicin—muscle cancer	0.000274	0.00131	CcSEcCtD
Fluticasone Propionate—Dizziness—Doxorubicin—muscle cancer	0.000265	0.00126	CcSEcCtD
Fluticasone Propionate—Vomiting—Doxorubicin—muscle cancer	0.000255	0.00122	CcSEcCtD
Fluticasone Propionate—Rash—Doxorubicin—muscle cancer	0.000252	0.0012	CcSEcCtD
Fluticasone Propionate—Dermatitis—Doxorubicin—muscle cancer	0.000252	0.0012	CcSEcCtD
Fluticasone Propionate—Headache—Doxorubicin—muscle cancer	0.000251	0.0012	CcSEcCtD
Fluticasone Propionate—Nausea—Doxorubicin—muscle cancer	0.000238	0.00114	CcSEcCtD
